Clinical trial • Phase I • Cardiology
AZD4063 for Dilated cardiomyopathy | PLN R14del dilated cardiomyopathy
Phase I trial of AZD4063 for Dilated cardiomyopathy | PLN R14del dilated cardiomyopathy. 36 participants.
Overview
- Trial Therapeutic Area
- Cardiology
- Trial Disease
- Dilated cardiomyopathy | PLN R14del dilated cardiomyopathy
- Trial Stage
- Phase I
Key dates
- Initial CTIS Submission Date
- 17-07-2025
- First CTIS Authorization Date
- 03-11-2025
Trial design
Phase I trial across 4 sites in Netherlands.
- Target Sample Size
- 36
Recruitment
- Planned Sample Size
- 36
- Recruitment Window Months
- 24
Geography
- Total Number Of Sites
- 4
- Total Number Of Participants
- 36
Netherlands
- Earliest CTIS Part Ii Submission Date
- 13-10-2025
- Latest Decision Or Authorization Date
- 23-03-2026
- Processing Time Days
- 161
- Number Of Sites
- 4
- Number Of Participants
- 36
Sites
- Site Name
- Universitair Medisch Centrum Groningen
- Department Name
- 5002:Cardiology
- Principal Investigator Name
- Peter Van der Meer
- Principal Investigator Email
- p.van.der.meer@umcg.nl
- Contact Person Name
- Peter Van der Meer
- Contact Person Email
- p.van.der.meer@umcg.nl
- Site Name
- Universitair Medisch Centrum Utrecht
- Department Name
- 5003:Cardiology
- Principal Investigator Name
- Linda W. Van Laake
- Principal Investigator Email
- L.W.vanLaake@umcutrecht.nl
- Contact Person Name
- Linda W. Van Laake
- Contact Person Email
- L.W.vanLaake@umcutrecht.nl
- Site Name
- Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
- Department Name
- 5001:Cardiology
- Principal Investigator Name
- Rudolf De Boer
- Principal Investigator Email
- r.a.deboer@erasmusmc.nl
- Contact Person Name
- Rudolf De Boer
- Contact Person Email
- r.a.deboer@erasmusmc.nl
- Site Name
- Amsterdam UMC Stichting
- Department Name
- 5004: unspecified
- Principal Investigator Name
- Ahmad Amin
- Principal Investigator Email
- a.s.amin@amsterdamumc.nl
- Contact Person Name
- Ahmad Amin
- Contact Person Email
- a.s.amin@amsterdamumc.nl
Sponsor
Primary sponsor
- Full Name
- AstraZeneca AB
- Organisation Type
- Pharmaceutical company
- Country Of Registered Address
- Sweden
Investigational products
- Investigational Product Name
- AZD4063
Related trials
Other published trials that may interest you.
- METHYLPREDNISOLONE for Fulminant myocarditis
- PELACARSEN for Cardiovascular disease | Arteriosclerotic cardiovascular disease
- clopidogrel for Acute coronary syndrome | Cardiovascular diseases
- APIXABAN for Venous thromboembolism
- SOTAGLIFLOZIN for Obstructive hypertrophic cardiomyopathy | Non-obstructive hypertrophic cardiomyopathy